Valuation: Sandu Pharmaceuticals Limited

Market Cap 295M 3.09M 2.68M 2.49M 2.3M 4.33M 4.41M 29.49M 11.55M 146M 11.6M 11.34M 492M P/E 2024
38x
P/E 2025 30.6x
Enterprise Value 273M 2.86M 2.48M 2.31M 2.13M 4.01M 4.08M 27.32M 10.7M 136M 10.74M 10.51M 456M EV / Sales 2024
0.81x
EV / Sales 2025 0.67x
Free-Float
-
Yield 2024
1.39%
Yield 2025 1.63%
06-19 Sandu Pharmaceuticals Limited Announces Demise of Umesh Sandu, Member of Audit Committee and Stakeholders Relationship Committee CI
06-19 Sandu Pharmaceuticals Limited Announces the Demise of Umesh Sandu, Managing Director CI
05-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-05 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March 2026 CI
02-06 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-12 Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
30/09/25 Sandu Pharmaceuticals Limited Approves the Continuation of Shri Vijay Kajarakar as Chief Financial Officer CI
13/08/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
29/05/25 Sandu Pharmaceuticals Posts INR3.3 Million Profit in Fiscal Q4 MT
28/05/25 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, on or Before October 25, 2025 CI
28/05/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/02/25 Sandu Pharmaceuticals Limited Announces Resignation of Shubhada Sandu as Non Executive Non Independent Director CI
13/02/25 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
1 day+2.86%
1 week-3.73%
Current month-3.66%
1 month-3.68%
3 months-12.03%
6 months+15.19%
Current year+5.53%
1 week 38
Extreme 38
41
1 month 37.3
Extreme 37.3
42
Current year 30
Extreme 30
50
1 year 30
Extreme 30
58.28
3 years 30
Extreme 30
85
5 years 30
Extreme 30
86
10 years 10.45
Extreme 10.45
86
Manager TitleAgeSince
Chief Executive Officer 58 11/07/2026
Director of Finance/CFO - 30/03/2024
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 62 01/06/2011
Chairman 58 30/03/2024
Director/Board Member 68 14/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%-3.73%-16.98%-23.29% 3.87M
+1.66%+2.03%-8.13%-2.84% 13.67B
+1.55%+1.12%-27.90%-49.28% 5.24B
+2.68%+7.72%+5.66%+8.93% 5.07B
-0.54%-1.83%+0.67%-32.86% 4.13B
+0.52%+1.62%+4.93%-3.89% 3.77B
+0.04%-1.97%-1.36%-2.85% 3.66B
-0.44%-0.75%-3.87%+10.66% 3.52B
-0.06%-2.38%-15.43%-24.06% 2.43B
+1.51%+4.73%+1.91%+49.65% 1.92B
Average +0.98%+2.66%-6.05%-6.98% 4.34B
Weighted average by Cap. +1.05%+3.73%-5.99%-7.79%

Financials

2024 2025
Net sales 673M 7.05M 6.12M 5.68M 5.24M 9.87M 10.05M 67.3M 26.35M 334M 26.47M 25.89M 1.12B 672M 7.04M 6.11M 5.68M 5.24M 9.86M 10.04M 67.21M 26.31M 334M 26.43M 25.85M 1.12B
Net income 14.61M 153K 133K 123K 114K 214K 218K 1.46M 572K 7.26M 575K 562K 24.4M 15.52M 163K 141K 131K 121K 228K 232K 1.55M 608K 7.71M 610K 597K 25.92M
Net Debt -11.43M -120K -104K -96.57K -89.06K -168K -171K -1.14M -448K -5.68M -450K -440K -19.09M -21.76M -228K -198K -184K -170K -319K -325K -2.18M -852K -10.8M -856K -837K -36.34M
Logo Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Employees
303
Date Price Change Volume
30/07/26 ₹39.50 +2.86% 330
29/07/26 ₹38.40 +1.05% 200
28/07/26 ₹38.00 -3.31% 646
27/07/26 ₹39.30 +0.03% 541
24/07/26 ₹39.29 -4.17% 3,304
  1. Stock Market
  2. Stocks
  3. SANDUPHQ6 Stock